Kailin Xu

7.4k citations
369 papers · 4.2k indexed · h-index 29
Topics
Hematopoietic Stem Cell Transplantation (70 papers)Immune Cell Function and Interaction (55 papers)CAR-T cell therapy research (53 papers)
Journals
Journal of the American Chemical SocietyNature CommunicationsSHILAP Revista de lepidopterología
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Kailin Xu

336 papers receiving 4.1k citations

Peers

Kailin Xu
Comparison fields: 5 of 137
  • Molecular Biology 1.7k
  • Hematology 1.2k
  • Oncology 1.1k
  • Immunology 959
  • Cancer Research 418
Replace Najmaldin Saki with:
Najmaldin Saki Iran
Xin Du China
Maria Felice Brizzi Italy
Hiranmoy Das United States
Anne‐Christine Bay‐Jensen Denmark
Lu H China
Hidetaka Sato Japan
Weina Chen United States
Hu Hu China
William A. Boisvert United States
Kailin Xu relative to Najmaldin Saki Iran Najmaldin Saki's profile →
Citations per field
00.5×2.6×
Najmaldin Saki · 1×
Citations per year

Countries citing papers authored by Kailin Xu

Since Specialization
Citations

This map shows the geographic impact of Kailin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kailin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kailin Xu more than expected).

Fields of papers citing papers by Kailin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kailin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kailin Xu. The network helps show where Kailin Xu may publish in the future.

Co-authorship network of co-authors of Kailin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Kailin Xu. A scholar is included among the top collaborators of Kailin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kailin Xu. Kailin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 0
3 3
4 6
5 1
6 4
7 6
8 1
9 3
10 0
11 15
12 2
13 3
14 17
15 8
16 23
17 77
18 46
19 11
20 1

About Kailin Xu

Kailin Xu is a scholar working on Hematology, Genetics and Immunology, having authored 369 papers that have together received 4.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (70 papers), Immune Cell Function and Interaction (55 papers) and CAR-T cell therapy research (53 papers). The work is most often cited by research in Hematology (1.2k citations), Immunology (959 citations) and Oncology (1.1k citations). Kailin Xu has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Lingyu Zeng, Jianlin Qiao, Jiang Cao, Bin Pan, Hai Cheng, Thomas Elliott, Wei Sang, Junnian Zheng, Zhiling Yan and Zhenyu Li. Their work appears in journals such as Journal of the American Chemical Society, Nature Communications and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026